title: The need for randomised controlled trials of isoniazid monoresistant tuberculosis treatment.
authors.affiliation: Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: larissa.otero@upch.pe.
authors.forename: Larissa
authors.initials: L
authors.lastname: Otero
authors.affiliation: Philadelphia Children's Hospital, University of Pennsylvania, PA, USA.
authors.forename: Leonela
authors.initials: L
authors.lastname: Villegas
authors.affiliation: University of Cincinnati College of Medicine, Cincinnati, OH, USA.
authors.forename: Moisés
authors.initials: M
authors.lastname: Huamán
authors.affiliation: Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Timothy
authors.initials: T
authors.lastname: Sterling
authors.affiliation: Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru.
authors.forename: Carlos
authors.initials: C
authors.lastname: Seas
mesh_terms: D000995:Antitubercular Agents; D006801:Humans; D007538:Isoniazid; D009169:Mycobacterium tuberculosis; D012293:Rifampin; D014376:Tuberculosis
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin